Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00798889 · ClinicalTrials.gov registry record · NA
Rollover Protocol for Prior SU011248 Protocols
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
- 314
- Enrollment target
NCT00798889 is a NA study that has completed, run by Pfizer. The registered enrollment target is 314 participants.
The verdict
NCT00798889, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
- 314 participants
- Enrollment target
Study Summary
The objective of this protocol is to provide SU011248 treatment for patients who have participated in a SU011248 protocol and are eligible to enter this protocol
Interventions
- DRUG Sunitinib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2004-03 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00798889
The ClinicalTrials.gov registry entry for NCT00798889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 314 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sunitinib is the first listed.
NCT00798889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00798889 about?
NCT00798889 is a clinical study titled "Rollover Protocol for Prior SU011248 Protocols". The objective of this protocol is to provide SU011248 treatment for patients who have participated in a SU011248 protocol and are eligible to enter this protocol
What is the current status of trial NCT00798889?
This trial is currently completed. It is a NA study. The enrollment target is 314 participants. The study started on 2004-03. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00798889?
The interventions under investigation include: Sunitinib (DRUG).
Who is sponsoring clinical trial NCT00798889?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.